Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst ...
Novo Nordisk says it will cut the price of Wegovy. This comes after a similar move by Zepound-maker Eli Lilly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback